Jaundice

Jaundice, also known as icterus, is a condition characterized by the yellowish discoloration of the skin, the sclera, and other mucous membranes due to elevated levels of bilirubin in the blood. It is a clinical sign rather than a disease itself, indicating an underlying disorder in the hepatic system, erythrocyte metabolism, or the Biliary tract. The condition is named from the French word "jaune," meaning yellow, and its management is a common concern in fields like Gastroenterology and Hepatology.

Signs and symptoms

The most apparent sign is a distinct yellow tint to the skin and the whites of the eyes, known as the sclera. This discoloration often follows a cephalocaudal progression, appearing first on the face before spreading downward. Patients frequently report dark-colored urine, as excess bilirubin is excreted by the kidneys, and clay-colored stools, indicating a lack of bile pigments in the intestines. Associated symptoms can include intense itching, generalized fatigue, right upper quadrant pain, and, in severe cases, signs of Hepatic encephalopathy such as mental confusion. In infants, poor feeding and lethargy may be observed, necessitating evaluation for Kernicterus.

Causes

Jaundice arises from three primary pathophysiological mechanisms: pre-hepatic, hepatic, and post-hepatic. Pre-hepatic causes involve excessive breakdown of red blood cells, overwhelming the liver's processing capacity, as seen in conditions like Sickle cell disease, Malaria, and Autoimmune hemolytic anemia. Hepatic causes result from the liver's inability to properly conjugate or secrete bilirubin, due to disorders such as Hepatitis (from viruses like Hepatitis B virus or toxins like acetaminophen), Cirrhosis (often from Alcoholic liver disease), and inherited conditions like Gilbert's syndrome or Crigler-Najjar syndrome. Post-hepatic, or obstructive, jaundice occurs when the flow of bile is blocked, commonly by choledocholithiasis, strictures, or tumors like Pancreatic cancer or Cholangiocarcinoma.

Pathophysiology

The pathophysiology centers on the metabolism of bilirubin, a yellow pigment derived from the breakdown of heme in senescent erythrocytes. Unconjugated bilirubin is bound to serum albumin and transported to the liver, where hepatocytes conjugate it with Glucuronic acid via the enzyme UDP-glucuronosyltransferase, making it water-soluble. This conjugated bilirubin is then excreted into the bile canaliculi and flows into the small intestine. In the colon, bacteria convert it to Urobilinogen, which is partly reabsorbed or oxidized to Stercobilin, giving stool its brown color. Disruption at any stage—increased production, impaired hepatic uptake/conjugation, or obstruction of biliary outflow—leads to bilirubin accumulation in tissues.

Diagnosis

Diagnosis begins with a thorough history and physical exam, noting the pattern of jaundice and associated findings like palpable liver or Courvoisier's sign. Initial laboratory evaluation includes a serum bilirubin panel to differentiate unconjugated from conjugated hyperbilirubinemia, along with Liver function tests assessing ALT, AST, and ALP. Imaging studies are crucial; abdominal ultrasound is often first-line to visualize the gallbladder and biliary tree, while computed tomography or MRCP provides more detail. In cases of obstruction, ERCP can be both diagnostic and therapeutic.

Treatment

Treatment is directed at the underlying cause. For unconjugated hyperbilirubinemia in newborns, blue light phototherapy is standard to convert bilirubin into excretable isomers. Severe hemolytic causes may require interventions like transfusions or treatment for underlying infections like Babesiosis. Hepatic causes, such as acute viral hepatitis, are managed supportively, while alcohol-related injury necessitates abstinence and nutritional support. Obstructive jaundice often requires procedural intervention; common bile duct stones are typically removed via ERCP, while malignant obstructions from pancreatic cancer might necessitate biliary stenting or surgical resection like the Whipple procedure. In end-stage liver disease, a transplant may be the only curative option.

Prognosis

The prognosis is entirely dependent on the etiology and timeliness of intervention. Benign conditions like Gilbert's syndrome confer an excellent prognosis with no impact on longevity. Jaundice from self-limiting hepatitis A infection typically resolves completely. However, jaundice secondary to advanced hepatic cirrhosis or aggressive malignancies like adenocarcinoma of the pancreas carries a much poorer outlook, often indicating advanced disease. Prompt diagnosis and management of obstructive causes can prevent complications like ascending cholangitis or hepatorenal syndrome, significantly improving outcomes.